Top Stories
-
Two teams at the Vagelos College of Physicians and Surgeons are working to train patients’ immune cells to seek and destroy rogue cells that cause cancer and autoimmune diseases.
Topic
-
Columbia cell therapy pioneer Michel Sadelain has received the 2025 Merkin Prize in Biomedical Technology and the 2025 King Faisal Prize in Medicine.
Topic
-
Through a trial offered at Columbia, a patient who is ineligible for existing treatments is the first to receive an experimental gene therapy.
Topic
-
A multi-institutional team of researchers developed a tiny implantable microphone, paving the way for fully internal cochlear implants.
Topic
Latest News
- July 10, 2014
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Topic
- May 12, 2014
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
Topic
- April 28, 2014
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.
Topic
- March 21, 2014
New way to classify gum disease may allow for earlier detection of severe cases before loss of teeth and bone occurs.
Topic
- March 13, 2014
Using stem cells from patients, P&S researchers have created a model of age-related macular degeneration in a dish, which may lead personalized treatments to prevent vision loss.
Topic
- December 1, 2013
For the first time, scientists have successfully transformed human stem cells into functional lung and airway cells.
Topic
- November 18, 2013
Columbia has honored Philipp E. Scherer, PhD for helping usher in a new understanding of fat and its role in diabetes and other metabolic diseases.
Topic
- September 11, 2013
A new genetic test may help determine which men with early prostate cancer can avoid surgery or other invasive treatment.
Topic
- August 9, 2013
Watch all eight talks from TEDMED Day CUMC, now available online.
Topic
